About
Enhanced Delivery of Gene Therapy
Areas of Focus
Categories
Drug Delivery & FormulationSan Diego & Southern California
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
4
As Collaborator
8
Total Enrollment
1,039
By Phase
PHASE1/PHASE2: 2PHASE1: 8PHASE2: 1
By Status
COMPLETED: 9ACTIVE_NOT_RECRUITING: 1TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06952439Lead Sponsor
Clinical Performance Evaluation of the Artificial Intelligence (AI)/ Machine Learning (ML) Technologies Utilized by the Origin Medical EXAM ASSISTANT
N/ACompleted
551 participants
Started: Mar 19, 2025 · Completed: May 19, 2025
NCT04357821Collaborator
Combinatorial Therapy to Induce an HIV Remission
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Aug 1, 2020 · Completed: Dec 31, 2025
NCT03718130Collaborator
Combination HTNV and PUUV DNA Vaccine
PHASE1Completed
61 participants
Started: Jul 10, 2019 · Completed: Oct 7, 2022
NCT02116205Collaborator
Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
PHASE2Completed
130 participants
Started: Jul 9, 2014 · Completed: Jul 31, 2017
NCT02099994Collaborator
Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults
PHASE1/PHASE2Completed
72 participants
Started: Mar 31, 2014 · Completed: Aug 31, 2015
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...